Epperly Melissa B,

Average Profitability
21.94%
Insider Buys Quantity
3
Insider Buys Sum
$1.22M
Insider Sells Quantity
18
Insider Sells Sum
$3.32M

Insider Activity of Epperly Melissa B,

According to the SEC Form 4 filings, Epperly Melissa B,, being in a position of

  1. Chief Financial Officer at Zentalis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11242 shares for $129,475,
    over all time since 2020-04-07, has bought 49611 share for $1.22M, and sold 85379 shares for $3.32M.

The largest purchase of all time was on 2020-04-07 and amounted to 40000 shares of Zentalis Pharmaceuticals, Inc. for $720,000.

The largest sale of all time was on 2021-04-05 and amounted to 17107 shares of Zentalis Pharmaceuticals, Inc. for $742,323.

Biography of Epperly Melissa B,

No biography is available at this moment.

2024-02-12SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
2,573
0.0036%
$11.44$29,435-60.7%
2024-02-02SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
8,669
0.0116%
$11.54$100,040-56.86%
2023-10-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
5,482
0.0076%
$19.50$106,926-39.88%
2023-02-14SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
5,227
0.0088%
$19.98$104,411-3.41%
2023-02-13SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
2,624
0.0044%
$20.42$53,594-4.99%
2022-04-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
353
0.0007%
$52.44$18,511-56.08%
2022-02-23SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
1,913
0.0044%
$49.10$93,921-49.3%
2021-08-19PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
8,285
0.0185%
$52.00$430,800-2.55%
2021-08-18PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
1,326
0.003%
$52.00$68,948-2.4%
2021-07-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0069%
$51.27$158,054+2.09%
2021-06-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0076%
$54.05$166,641+0.28%
2021-05-03SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0075%
$59.24$182,635-6.79%
2021-04-05SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
17,107
0.0417%
$43.39$742,323+29.58%
2021-03-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0076%
$41.67$128,482+36.07%
2021-02-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0075%
$37.56$115,805+48.32%
2021-01-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0075%
$51.91$160,034+3.81%
2020-12-07SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
6,464
0.0229%
$53.52$345,963-0.93%
2020-12-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
7,220
0.0257%
$50.98$368,097+4.37%
2020-12-02SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.011%
$51.47$158,681+4.08%
2020-11-23SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
6,166
0.022%
$46.58$287,227+13.3%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.